GlassScriptPhysician profile
Michael D Goodyear
NPI 1962499822
$1,542.59
in general payments reported to CMS, 2019-2025
14 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $67.90 · 2021: $34.34 · 2022: $83.65 · 2023: $330 · 2024: $369 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $852.07 | 2019-2025 | Puraply, Puraply Wound Matrix, Puraply Am |
| Smith+Nephew, INC. | $164.46 | 2019-2024 | Stravix, Grafix Pl |
| Solventum Corporation | $146.31 | 2025 | Activ.A.C., Promogran Prisma |
| Abbvie INC. | $96.49 | 2021-2023 | |
| Kerecis Limited | $91.07 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $36.50 | 2020 | |
| Integra Lifesciences Corporation | $28.88 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Melinta Therapeutics, LLC | $21.78 | 2019 | |
| Normatec Industries, LP | $21.43 | 2019 | |
| Bsn Medical INC | $19.97 | 2024 | |
| Mimedx Group, INC. | $18.10 | 2024 | |
| Paratek Pharmaceuticals, INC. | $17.13 | 2024 | Nuzyra |
| Cashflow Solutions, LLC | $17.10 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| 3m Company | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Goodyear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.